Hongfeng Investment Management
VC Fund
Qingpu, China
Hongfeng Investment Management is an investment firm.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 14%
Last updated:
For AI agents: llms.txt
Industries Hongfeng Investment Management invests in
Stages Hongfeng Investment Management invests in
Countries Hongfeng Investment Management invests in
Investment Focus
Industry
- Biotechnology 4 (57%)
- Health Care 2 (29%)
- Medical 1 (14%)
- Big Data 1 (14%)
- Software 1 (14%)
Stage
- Series A 3 (43%)
- Seed 2 (29%)
- Angel 1 (14%)
- Series B 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Dianxin Technology is a company that manufactures microLED and chiplet process measurement equipment. Dianxin Technology has created non-reference position measuring and defect detection equipment for mass transfer, giving tools for managing MicroLED yield. | $14M / Series A / Nov 07, 2024 | ||
| Leadopharma engages in the research and development of drugs targeting pain, epilepsy, depression, and neurodegenerative diseases. Leadopharma has established a complete pharmaceutical chemistry and ion channel drug research and development platform and team, which can independently carry out drug synthesis, activity screening, and early safetypharmacology research for ion channel targets. | Series A / Aug 07, 2023 | ||
| Zilixir Biotech develops a new protein design technology that offers possibilities for human exploration of the complex life sciences. SWORD™ protein design technology integrates binding pockets, new drug skeleton design, activity prediction, ADME/T prediction, etc., and has had some achievements in these areas, fully demonstrating theeffectiveness of protein design. | $14.1M / Series A / May 25, 2023 | ||
| Jianxin Bio focuses on new monoclonal antibody drugs, CAR-T (Chimeric Antigen Receptor T Cell) technology innovation. | Series B / Mar 20, 2023 | ||
| Shuxin Network is a big data service solution provider focusing on cloud data platforms. The company can provide one-stop services from data aggregation to data services, efficient modeling, intelligent operation and maintenance, and intelligent analysis, allowing data from collection to presentation. , From the analysis to the driving application,the high-quality combination is obtained, and the overall competitiveness of the enterprise is improved. | Seed / Aug 25, 2022 | ||
| T-Maximum develops CAR-T cell therapies for the treatment of brain tumors. T-Maximum's gene-editing allogeneic immune cell therapy adopts the version 3.0 program with completely independent intellectual property rights to realize allogeneic universal CAR-T therapy and solve the risk of graft-versus-host disease and rejection of allogeneicimmune cells. | Angel / Aug 20, 2021 | ||
| Leadopharma engages in the research and development of drugs targeting pain, epilepsy, depression, and neurodegenerative diseases. Leadopharma has established a complete pharmaceutical chemistry and ion channel drug research and development platform and team, which can independently carry out drug synthesis, activity screening, and early safetypharmacology research for ion channel targets. | Seed / Jul 01, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Hongfeng Investment Management invest in?
Hongfeng Investment Management invests primarily in Biotechnology, Health Care and Medical startups, most often at Series A and Seed stage. Most of the 7 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Hongfeng Investment Management last invest?
The most recent investment recorded for Hongfeng Investment Management closed in Nov 2024. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
